DCDi Chen

Di Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Di Chen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Changyudong Huang

    Prenatal Diagnosis Center Affiliated Hospital of Guizhou Medical University Guiyang Guizhou People's Republic of China

    1 shared publication
  • Chengcheng Li

    Prenatal Diagnosis Center Affiliated Hospital of Guizhou Medical University Guiyang Guizhou People's Republic of China

    1 shared publication
  • Haizhi Li

    Prenatal Diagnosis Center Affiliated Hospital of Guizhou Medical University Guiyang Guizhou People's Republic of China

    1 shared publication
  • Huiru Yang

    Prenatal Diagnosis Center Affiliated Hospital of Guizhou Medical University Guiyang Guizhou People's Republic of China

    1 shared publication
  • Liying Zhu

    School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; Center for Clinical Laboratories, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, PR China

    1 shared publication
  • Mi Liu

    Guizhou Prenatal Diagnosis Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, PR China; Department of Molecular Pathology Laboratory, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou 550000, PR China

    1 shared publication

Latest Publications

  • Open Access

    Glycemic Variability and Gut Microbiota Metabolic Patterns: A Novel Perspective on Diabetic Complications

    by Yongjie Xu, Di Chen, Huiru Yang, Yiqiong Zhang, Changyudong Huang, Yinxue Zhong, Haizhi Li, Liying Zhu, Chengcheng Li, Rui Yan, et al.

    Emerging evidence indicates a critical link between diabetic complications and the interplay of glycemic variability and gut microbiota metabolic activity. This review comprehensively examines the regulatory effects of glycemic fluctuations on the composition and function of the gut microbiota, while elucidating the key mechanisms by which microbial metabolic reprogramming—mediated through short‐chain fatty acids, bile acids, and other metabolites—disrupts host metabolic and immune homeostasis, thereby exacerbating diabetic complications. Research demonstrates that glycemic variability not only directly contributes to vascular and neuronal damage but also remodels the gut microbiota's metabolic network, triggering systemic metabolic dysregulation and chronic low‐grade inflammation. Building on these findings, we explore novel therapeutic strategies targeting the gut microbiota for the prevention and management of diabetic complications. By adopting a “gut‐organ axis” framework, this study unveils the cascade of interactions among glycemic variability, gut microbiota, and metabolic disturbances in the pathogenesis of diabetic complications, offering both theoretical foundations and innovative approaches for clinical intervention.